Dramatic mitigation of bone pain after phosphorus replacement therapy in a subject with FGF23-related hypophosphatemic osteomalacia

INTRODUCTION: Fibroblast growth factor 23 (FGF23) is secreted from bone and suppresses the absorption of phosphorus in renal proximal tubule and in intestinal tract. Therefore, the increase of serum FGF23 levels leads to hypophosphatemic situations. Tumor-induced osteomalacia is often induced by var...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatsumi, Fuminori, Horiya, Megumi, Tanabe, Akihito, Nishioka, Momoyo, Fushimi, Yoshiro, Sanada, Junpei, Hirata, Yurie, Irie, Shintaro, Kinoshita, Tomoe, Kamei, Shinji, Shimoda, Masashi, Mune, Tomoatsu, Kaku, Kohei, Kaneto, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093104/
https://www.ncbi.nlm.nih.gov/pubmed/27867811
http://dx.doi.org/10.1186/s40064-016-3602-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093104/
https://www.ncbi.nlm.nih.gov/pubmed/27867811
http://dx.doi.org/10.1186/s40064-016-3602-6

Ejemplares similares